Suppr超能文献

菲茨杰拉德性状中的激肽原缺乏:高分子量激肽原在凝血和纤维蛋白溶解中的作用。

Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.

作者信息

Donaldson V H, Glueck H I, Miller M A, Movat H Z, Habal F

出版信息

J Lab Clin Med. 1976 Feb;87(2):327-37.

PMID:1245795
Abstract

Plasma from an asymptomatic person with defects in blood coagulation, release of kinin, and evolution of fibrinolytic activity upon contact with a foreign surface was deficient in kininogen. The coagulation defect was identified as "Fitzgerald trait." A preparation of high molecular weight kininogen repaired the defects in clotting, kinin release and fibrinolysis, but a preparation of low molecular weight kininogen did not. Therefore, Fitzgerald factor appears to be a high molecular weight kininogen. The site of action of the kininogen appears to be after that of activated Hageman factor and kallikrein in the generation of clot-promoting activity through activation of plasma thromboplastin antecedent (PTA).

摘要

一名无症状但存在血液凝固缺陷、激肽释放以及接触异物表面时纤溶活性变化的人的血浆中激肽原缺乏。这种凝血缺陷被确定为“菲茨杰拉德特征”。高分子量激肽原制剂修复了凝血、激肽释放和纤溶方面的缺陷,但低分子量激肽原制剂则不能。因此,菲茨杰拉德因子似乎是一种高分子量激肽原。在通过激活血浆凝血活酶前体(PTA)产生促进凝血活性的过程中,激肽原的作用位点似乎在活化的哈格曼因子和激肽释放酶之后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验